hotspot -WSS

hotspot

author：entertainment 2025-09-06 04:12:56 - browse：358

Novo Nordisk headquarters -- health coverage from STAT — LISELOTTE SABROE/Scanpix/AFP via Getty Images

Fresh off of the news that its drug Wegovy may not just help people lose weight, but could also lower cardiac risks, Novo Nordisk doubled down on its obesity drug pipeline Thursday, acquiring a small Canadian biotech with a new approach to weight loss.

Novo will spend up to $1 billion to buy Inversago Pharma, which is developing an oral obesity drug that targets the cannabinoid receptor CB1. It’s the second big obesity acquisition this year, following Eli Lilly’s move to purchase startup Versanis Bio.

Drugs like Wegovy are in a class called GLP-1 drugs, which mimic the effects of the glucagon-like peptide 1 hormone that help people feel full by targeting the hormone’s receptors.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Hottest summer in 2,000 years puts focus on extreme heat, health

WSS

Readout Newsletter: Raw milk, Wegovy tests, Eisai and Biogen

The White House hikes tariffs on plastic syringes made in China

Readout Newsletter: Biogen, Ionis, Johnson & Johnson news

Amylyx ALS drug fails large clinical trial

Readout Newsletter: Amylyx, Alto Neuro, and Eli Lilly for the Oscars

Adam's Biotech Scorecard: PDS Biotech's survival benefit is overstated

Wikipedia

hotspot

focus

Medicare proposal to cover medical devices draws a mixed reaction

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

Hollywood unions extend contract negotiations for actors

Sen. Paul opposes bill to ban Chinese biotechs

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

In surprise move, FDA calls for advisory committee on Lilly's Alzheimer's drug

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

The problem with charging patients to message their doctors

Peter Hotez and the public health issue of online harassment

The United States must get value

explore

Change Healthcare cyberattack prompts Medicare loan program

UnitedHealth quietly bought dozens of outpatient centers

Former medical device CEO who sold dummy, plastic parts convicted of fraud

Supreme Court to hear if Covid misinformation is protected speech

In his State of the Union, Biden takes clear aim at 'Big Pharma'

In his State of the Union, Biden takes clear aim at 'Big Pharma'

leisure time

explore

hotspot

hotspot